Rasagiline (Rasagiline) (Tablet) 0.5 mg/1

Rasagiline 0.5 mg tablets are prescribed for managing Parkinson’s disease symptoms. This MAO-B inhibitor supports dopamine activity in the brain. A once-daily tablet option for adults. Suitable for patients seeking adjunct therapy or monotherapy.

Strength

0.5 mg/1

Manufacturer / TM Owner

Alvogen, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rasagiline 0.5 mg tablets are used to treat symptoms of Parkinson’s disease, including tremors, stiffness, and movement difficulties. It may be prescribed alone or with other medications to improve daily function. Patients often ask, what is rasagiline used for in Parkinson’s disease management? This medication helps maintain motor control by supporting dopamine levels in the brain.

Side Effects

Rasagiline 0.5 mg tablets may help reduce Parkinson’s symptoms such as shaking, rigidity, and slow movement. Some users notice improved balance and coordination over time. Effects can vary by individual, and consistent use is important for best results.

Precautions & Warnings

Store rasagiline 0.5 mg tablets at room temperature away from moisture and heat. Keep out of reach of children and pets. Avoid crushing or splitting tablets unless directed. Report any unusual changes to a healthcare provider promptly.

Avoid Interactions

Rasagiline 0.5 mg may interact with certain antidepressants, opioids, or cold/cough medicines. Avoid foods high in tyramine, such as aged cheeses or cured meats, to reduce risk of side effects. Always inform your doctor about all medications and supplements you take.

Frequently Asked Questions

Rasagiline 0.5 mg is used to treat symptoms of Parkinson’s disease, including tremors and stiffness.

Store rasagiline tablets at room temperature, away from moisture and heat.

Rasagiline may be prescribed with other medications, but always consult a healthcare provider before combining treatments.

Avoid foods high in tyramine, such as aged cheeses or cured meats, to reduce the risk of side effects.

Rasagiline is not classified as a controlled substance but requires careful monitoring due to potential interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.